HGC Investment Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-200,000
Closed -$11.2K 165
2023
Q3
$11.2K Hold
200,000
﹤0.01% 86
2023
Q2
$26K Buy
+200,000
New +$20.7K 0.01% 77

HGC Investment Management's BIOSW Position: Q4 2023 in Review

HGC Investment Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 200,000 shares — an estimated $11.2K sold.

HGC Investment Management first reported a position in BIOSW in Q2 2023 and held it in 2 quarters. The position peaked at $26K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • HGC Investment Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • HGC Investment Management sold 200,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $11.2K.
  • HGC Investment Management first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2023 and held it in 2 quarters.
  • HGC Investment Management's BioPlus Acquisition Corp. Warrants position peaked at $26K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on HGC Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.